Banner Health McKee Medical Center

SPR 2017

Spirit of Women magazine is a national publication presented to women by hospitals and their physicians. The magazine provides up-to-date, evidence-based healthcare information and promotes our hospitals as leaders in women's health excellence.

Issue link:

Contents of this Issue


Page 19 of 31

20 Cancer Care SHUTTERSTOCK that offer new hope for patients whose lung cancer has advanced. These new treatments are especially important for lung cancer—the second-leading cause of cancer deaths for women worldwide—because the disease doesn't produce symptoms in the early stages, so most people aren't diagnosed until it has spread. "It has changed the way we treat lung cancer," says Dr. Marte. "It opens up many opportunities we never had before. It's important to have a large toolbox of therapeutic options." Let's take a look at the medical advancements that are helping late-stage lung cancer patients live longer, more comfortable lives. for advanced lung cancer treatments E ighteen months ago, Dr. Michael Marte began prescribing a targeted therapy drug to one of his patients who had stage 4 lung cancer. Instead of undergoing intravenous infusions at a medical facility, the 69-year-old woman simply swallows a pill at home, without any unpleasant side effects. And today, her CT (computerized tomography) scans show no evidence of the lung cancer. Ten years ago, this type of treatment with the drug erlotinib (Tarceva) wouldn't even have been possible, says Dr. Marte, a medical oncologist at Pocono Medical Center in East Stroudsburg, Pa. But now it's just one of a number of targeted therapy and immunotherapy options By Teresa Meek New hope

Articles in this issue

Archives of this issue

view archives of Banner Health McKee Medical Center - SPR 2017